1. GPCR/G Protein Neuronal Signaling
  2. Melanocortin Receptor
  3. Melanotan (MT)-II

Melanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Kundenspezifische Peptidsynthese

Melanotan (MT)-II

Melanotan (MT)-II Chemische Struktur

CAS. Nr. : 121062-08-6

Größe Preis Verfügbarkeit Menge
1 mg Auf Lager
5 mg Auf Lager
10 mg Auf Lager
25 mg Auf Lager
50 mg Auf Lager
100 mg Auf Lager
200 mg   Angebot einholen  
500 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 publication(s) in Google Scholar

Other Forms of Melanotan (MT)-II:

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Melanotan (MT)-II

Alle Melanocortin Receptor Isoform-spezifische Produkte anzeigen:

  • Biologische Aktivität

  • Protokoll

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

Melanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning.

Cellular Effect
Cell Line Type Value Description References
A-375 EC50
110 nM
Compound: MT-II
Agonist activity at human MC1 receptor expressed in A375 cells assessed as intracellular cAMP accumulation using [3H]-cAMP by luminescence counting
Agonist activity at human MC1 receptor expressed in A375 cells assessed as intracellular cAMP accumulation using [3H]-cAMP by luminescence counting
[PMID: 26218460]
A-375 IC50
6.7 nM
Compound: MT-II
Antagonist activity at human MC1 receptor expressed in A375 cells assessed as inhibition of MT-II-induced intracellular cAMP accumulation using [3H]-cAMP by luminescence counting
Antagonist activity at human MC1 receptor expressed in A375 cells assessed as inhibition of MT-II-induced intracellular cAMP accumulation using [3H]-cAMP by luminescence counting
[PMID: 26218460]
HEK293 EC50
0.02 nM
Compound: MTII
Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells
[PMID: 12477357]
HEK293 EC50
0.021 nM
Compound: MTII
Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay
[PMID: 15615519]
HEK293 EC50
0.03 nM
Compound: MT-II
Activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
Activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
[PMID: 25347033]
HEK293 EC50
0.04 nM
Compound: MTII
Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay
[PMID: 15615519]
HEK293 EC50
0.05 nM
Compound: MTII
Agonist activity at mouse melanocortin-4 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
Agonist activity at mouse melanocortin-4 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
[PMID: 25699138]
HEK293 EC50
0.06 nM
Compound: MT-II
Activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
Activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
[PMID: 25347033]
HEK293 EC50
0.087 nM
Compound: MTII
Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells
[PMID: 12477357]
HEK293 EC50
0.16 nM
Compound: MTII
Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells
Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells
[PMID: 12477357]
HEK293 EC50
0.16 nM
Compound: MTII
Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells
[PMID: 12477357]
HEK293 EC50
0.17 nM
Compound: MTII
Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay
[PMID: 15615519]
HEK293 EC50
0.18 nM
Compound: MT-II
Activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
Activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
[PMID: 25347033]
HEK293 EC50
0.18 nM
Compound: MTII
Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay
[PMID: 15615519]
HEK293 EC50
0.19 nM
Compound: MT-II
Activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
Activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay
[PMID: 25347033]
HEK293 EC50
0.22 nM
Compound: MTII
Agonist activity at mouse melanocortin-1 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
Agonist activity at mouse melanocortin-1 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
[PMID: 25699138]
HEK293 EC50
0.3 nM
Compound: 17
Activity against hMC1R transfected in HEK293 cells by intracellular cAMP accumulation
Activity against hMC1R transfected in HEK293 cells by intracellular cAMP accumulation
[PMID: 16539382]
HEK293 EC50
0.3 nM
Compound: MT-II
Agonist activity at human MC1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 18088090]
HEK293 EC50
0.3 nM
Compound: MTII
Activity at hMC1R transfected in HEK293 cells assessed as intracellular cAMP accumulation
Activity at hMC1R transfected in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 17154518]
HEK293 EC50
0.3 nM
Compound: MTII
Agonist activity at human MC1R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
Agonist activity at human MC1R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
[PMID: 19473029]
HEK293 EC50
0.35 nM
Compound: MTII
Agonist activity at mouse melanocortin-3 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
Agonist activity at mouse melanocortin-3 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
[PMID: 25699138]
HEK293 EC50
0.57 nM
Compound: MTII
Agonist activity at mouse melanocortin-5 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
Agonist activity at mouse melanocortin-5 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay
[PMID: 25699138]
HEK293 EC50
1 nM
Compound: MT-II
Activity at human MC1R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
Activity at human MC1R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
[PMID: 16931008]
HEK293 EC50
1.02 nM
Compound: MT-II
Agonist activity at human MC1R expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation
Agonist activity at human MC1R expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation
[PMID: 21486697]
HEK293 EC50
1.02 nM
Compound: MT-II
Activity at human MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
Activity at human MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
[PMID: 25699148]
HEK293 EC50
1.8 nM
Compound: MT-II
Agonist activity at human melanocortin 1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
Agonist activity at human melanocortin 1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
[PMID: 26599352]
HEK293 EC50
1.8 nM
Compound: MT-II
Agonist activity at human melanocortin 3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
Agonist activity at human melanocortin 3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
[PMID: 26599352]
HEK293 EC50
1.85 nM
Compound: MT-II
Agonist activity at human MC3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 18088090]
HEK293 EC50
1.9 nM
Compound: 17
Activity against hMC3R transfected in HEK293 cells by intracellular cAMP accumulation
Activity against hMC3R transfected in HEK293 cells by intracellular cAMP accumulation
[PMID: 16539382]
HEK293 EC50
1.9 nM
Compound: MTII
Activity at hMC3R transfected in HEK293 cells assessed as intracellular cAMP accumulation
Activity at hMC3R transfected in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 17154518]
HEK293 EC50
1.9 nM
Compound: MTII
Agonist activity at human MC3R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
Agonist activity at human MC3R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
[PMID: 19473029]
HEK293 EC50
2.1 nM
Compound: MT-II
Agonist activity at human MC4R expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC4R expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 21486697]
HEK293 EC50
2.1 nM
Compound: MT-II
Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
[PMID: 25699148]
HEK293 EC50
2.3 nM
Compound: MT-II
Activity at human MC4R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
Activity at human MC4R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
[PMID: 16931008]
HEK293 EC50
2.4 nM
Compound: MT-II
Activity at human MC3R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
Activity at human MC3R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
[PMID: 16931008]
HEK293 EC50
2.87 nM
Compound: MT-II
Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 18088090]
HEK293 EC50
2.9 nM
Compound: 17
Activity against hMC4R transfected in HEK293 cells by intracellular cAMP accumulation
Activity against hMC4R transfected in HEK293 cells by intracellular cAMP accumulation
[PMID: 16539382]
HEK293 EC50
2.9 nM
Compound: MT-II
Agonist activity at human melanocortin 4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
Agonist activity at human melanocortin 4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
[PMID: 26599352]
HEK293 EC50
2.9 nM
Compound: MTII
Activity at hMC4R transfected in HEK293 cells assessed as intracellular cAMP accumulation
Activity at hMC4R transfected in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 17154518]
HEK293 EC50
2.9 nM
Compound: MTII
Agonist activity at human MC4R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
Agonist activity at human MC4R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
[PMID: 19473029]
HEK293 EC50
3.1 nM
Compound: MT-II
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay
[PMID: 28972753]
HEK293 EC50
3.3 nM
Compound: 17
Activity against hMC5R transfected in HEK293 cells by intracellular cAMP accumulation
Activity against hMC5R transfected in HEK293 cells by intracellular cAMP accumulation
[PMID: 16539382]
HEK293 EC50
3.3 nM
Compound: MT-II
Agonist activity at human MC5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 18088090]
HEK293 EC50
3.3 nM
Compound: MT-II
Agonist activity at human melanocortin 5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
Agonist activity at human melanocortin 5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX
[PMID: 26599352]
HEK293 EC50
3.3 nM
Compound: MTII
Activity at hMC5R transfected in HEK293 cells assessed as intracellular cAMP accumulation
Activity at hMC5R transfected in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 17154518]
HEK293 EC50
3.3 nM
Compound: MTII
Agonist activity at human MC5R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
Agonist activity at human MC5R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level
[PMID: 19473029]
HEK293 EC50
33.9 nM
Compound: MT-II
Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
[PMID: 28972753]
HEK293 EC50
33.9 nM
Compound: MT-II
Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
[PMID: 28972753]
HEK293 EC50
5.1 nM
Compound: MT-II
Agonist activity at human MC3R expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC3R expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 21486697]
HEK293 EC50
5.1 nM
Compound: MT-II
Activity at human MC3 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
Activity at human MC3 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
[PMID: 25699148]
HEK293 EC50
5.7 nM
Compound: MT-II
Agonist activity at human MC5R expressed in HEK293 cells assessed as intracellular cAMP accumulation
Agonist activity at human MC5R expressed in HEK293 cells assessed as intracellular cAMP accumulation
[PMID: 21486697]
HEK293 EC50
5.7 nM
Compound: MT-II
Antagonist activity at human MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
Antagonist activity at human MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter
[PMID: 25699148]
HEK293 EC50
8 nM
Compound: MT-II
Activity at human MC5R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
Activity at human MC5R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation
[PMID: 16931008]
HEK293 EC50
8.6 nM
Compound: MT-II
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
[PMID: 28972753]
HEK293 IC50
0.1 nM
Compound: MT-II
Displacement of [125I]NDP-alpha-MSH from human MC1R expressed in HEK293 cells
Displacement of [125I]NDP-alpha-MSH from human MC1R expressed in HEK293 cells
[PMID: 16931008]
HEK293 IC50
0.2 nM
Compound: 17
Inhibitory activity against hMC1R transfected in HEK293 cells
Inhibitory activity against hMC1R transfected in HEK293 cells
[PMID: 16539382]
HEK293 IC50
0.2 nM
Compound: MT-II
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC1 receptor expressed in HEK293 cells
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC1 receptor expressed in HEK293 cells
[PMID: 18088090]
HEK293 IC50
0.2 nM
Compound: MTII
Displacement of [125I]NDP-alphaMSH from human MC1 receptor expressed in HEK293 cells
Displacement of [125I]NDP-alphaMSH from human MC1 receptor expressed in HEK293 cells
[PMID: 17154518]
HEK293 IC50
0.2 nM
Compound: MTII
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC1R expressed in HEK293 cells
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC1R expressed in HEK293 cells
[PMID: 19473029]
HEK293 IC50
1 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC1 receptor expressed in HEK293 cells by gamma counting analysis
Displacement of [125I]-NDP-alpha-MSH from human MC1 receptor expressed in HEK293 cells by gamma counting analysis
[PMID: 25699148]
HEK293 IC50
1.07 nM
Compound: MT-II
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC4 receptor expressed in HEK293 cells
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC4 receptor expressed in HEK293 cells
[PMID: 18088090]
HEK293 IC50
1.1 nM
Compound: 17
Inhibitory activity against hMC4R transfected in HEK293 cells
Inhibitory activity against hMC4R transfected in HEK293 cells
[PMID: 16539382]
HEK293 IC50
1.1 nM
Compound: MT-II
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 4 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 4 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
[PMID: 26599352]
HEK293 IC50
1.1 nM
Compound: MTII
Displacement of [125I]NDP-alphaMSH from human MC4 receptor expressed in HEK293 cells
Displacement of [125I]NDP-alphaMSH from human MC4 receptor expressed in HEK293 cells
[PMID: 17154518]
HEK293 IC50
1.1 nM
Compound: MTII
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC4R expressed in HEK293 cells
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC4R expressed in HEK293 cells
[PMID: 19473029]
HEK293 IC50
1.2 nM
Compound: MT-II
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 1 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 1 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
[PMID: 26599352]
HEK293 IC50
1.2 nM
Compound: MT-II
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 3 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 3 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
[PMID: 26599352]
HEK293 IC50
1.25 nM
Compound: MT-II
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC3 receptor expressed in HEK293 cells
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC3 receptor expressed in HEK293 cells
[PMID: 18088090]
HEK293 IC50
1.3 nM
Compound: 17
Inhibitory activity against hMC3R transfected in HEK293 cells
Inhibitory activity against hMC3R transfected in HEK293 cells
[PMID: 16539382]
HEK293 IC50
1.3 nM
Compound: MTII
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC3R expressed in HEK293 cells
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC3R expressed in HEK293 cells
[PMID: 19473029]
HEK293 IC50
1.8 nM
Compound: MT-II
Displacement of [125I]NDP-alpha-MSH from human MC4R expressed in HEK293 cells
Displacement of [125I]NDP-alpha-MSH from human MC4R expressed in HEK293 cells
[PMID: 16931008]
HEK293 IC50
1.9 nM
Compound: MT-II
Displacement of [125I]NDP-alpha-MSH from human MC3R expressed in HEK293 cells
Displacement of [125I]NDP-alpha-MSH from human MC3R expressed in HEK293 cells
[PMID: 16931008]
HEK293 IC50
2 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC3 receptor expressed in HEK293 cells by gamma counting analysis
Displacement of [125I]-NDP-alpha-MSH from human MC3 receptor expressed in HEK293 cells by gamma counting analysis
[PMID: 25699148]
HEK293 IC50
2 nM
Compound: MTII
Displacement of [125I]NDP-alphaMSH from human MC3 receptor expressed in HEK293 cells
Displacement of [125I]NDP-alphaMSH from human MC3 receptor expressed in HEK293 cells
[PMID: 17154518]
HEK293 IC50
2.3 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
[PMID: 21486697]
HEK293 IC50
2.3 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC4R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
Displacement of [125I]-NDP-alpha-MSH from human MC4R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
[PMID: 21486697]
HEK293 IC50
2.3 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC4 receptor expressed in HEK293 cells by gamma counting analysis
Displacement of [125I]-NDP-alpha-MSH from human MC4 receptor expressed in HEK293 cells by gamma counting analysis
[PMID: 25699148]
HEK293 IC50
4.2 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC5R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
Displacement of [125I]-NDP-alpha-MSH from human MC5R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
[PMID: 21486697]
HEK293 IC50
4.2 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC5 receptor expressed in HEK293 cells by gamma counting analysis
Displacement of [125I]-NDP-alpha-MSH from human MC5 receptor expressed in HEK293 cells by gamma counting analysis
[PMID: 25699148]
HEK293 IC50
7 nM
Compound: MT-II
Displacement of [125I]NDP-alpha-MSH from human MC5R expressed in HEK293 cells
Displacement of [125I]NDP-alpha-MSH from human MC5R expressed in HEK293 cells
[PMID: 16931008]
HEK293 IC50
7.47 nM
Compound: MT-II
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC5 receptor expressed in HEK293 cells
Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC5 receptor expressed in HEK293 cells
[PMID: 18088090]
HEK293 IC50
7.5 nM
Compound: 17
Inhibitory activity against hMC5R transfected in HEK293 cells
Inhibitory activity against hMC5R transfected in HEK293 cells
[PMID: 16539382]
HEK293 IC50
7.5 nM
Compound: MT-II
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 5 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 5 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis
[PMID: 26599352]
HEK293 IC50
7.5 nM
Compound: MTII
Displacement of [125I]NDP-alphaMSH from human MC5 receptor expressed in HEK293 cells
Displacement of [125I]NDP-alphaMSH from human MC5 receptor expressed in HEK293 cells
[PMID: 17154518]
HEK293 IC50
7.5 nM
Compound: MTII
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC5R expressed in HEK293 cells
Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC5R expressed in HEK293 cells
[PMID: 19473029]
HEK293 IC50
8 nM
Compound: MT-II
Displacement of [125I]-NDP-alpha-MSH from human MC3R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
Displacement of [125I]-NDP-alpha-MSH from human MC3R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting
[PMID: 21486697]
In Vitro

Melanotan (MT)-II is a potent non-selective melanocortin receptor agonist with high affinity for MC1, MC3, MC4, and MC5 receptor subtypes which are involved in the regulation of a number of physiological systems such as the pigmentary system, energy homoeostasis, sexual functioning, the immune system, inflammation, and the cardiovascular system[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Melanotan (MT)-II exerts a dose-dependent inducer activity on erection by eliciting erectile events and shortening latency of the first erectile event to occur. Erectile responses elicited by cavernous nerve stimulation are increased after i.v. melanotan (MT)-II (1 mg/kg), thereby exerting facilitator effect on erection[2].
Melanotan (MT)-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat. Melanotan (MT)-II significantly enhances the recovery of sensory function following a crush lesion of the sciatic nerve in the rat at a dose of 20 μg/kg per 48 h, s.c., but not at a dose of 2 or 50 μg/kg[3].
Melanotan (MT)-II is a potent initiator of penile erection in men with erectile dysfunction[4].
Melanotan (MT)-II reduces food intake and body weight and invokes thermogenic responses in a mouse model[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molekulargewicht

1024.18

Formel

C50H69N15O9

CAS. Nr.
Appearance

Solid

Color

White to off-white

Sequence

Ac-{Nle}-Asp-His-{d-Phe}-Arg-Trp-Lys-NH2, (2→7)-lactam

Sequence Shortening

Ac-{Nle}-DH-{d-Phe}-RWK-NH2, (2→7)-lactam

Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Sealed storage, away from moisture

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Lösungsmittel & Löslichkeit
In Vitro: 

H2O : 6.67 mg/mL (6.51 mM; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 0.9764 mL 4.8820 mL 9.7639 mL
5 mM 0.1953 mL 0.9764 mL 1.9528 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • Molaritätsrechner

  • Verdünnungsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
Reinheit & Dokumentation

Purity: 99.97%

Verweise
Tierverwaltung
[2][5]

Rats: To investigate the inducer activity on erection, melanotan (MT)-II or vehicle (saline) is acutely injected i.v., i.t. or within the PVN after a 5 min baseline recording period is obtained. ICP and MAP are then recorded for a 60 min period after saline or melanotan (MT)-II delivery. I.v. injections (three doses; 0.1, 0.3, and 1 mg/kg in saline) are performed with a catheter inserted in the jugular vein[2].

Mice: Melanotan (MT)-II (0.1 and 0.2 nM) or vehicle (artificial cerebrospinal fluid) is administered. SPA is recorded continuously every 5 min. Food intake measurements are taken 6 and 24 h postinjection. Body weight is measured every 24 h. Chow and water are available ad libitum. A 48-h interval occurrs between drug treatments[5].

MCE hat die Genauigkeit dieser Methoden nicht unabhängig bestätigt. Sie dienen nur als Referenz.

Verweise

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 0.9764 mL 4.8820 mL 9.7639 mL 24.4098 mL
5 mM 0.1953 mL 0.9764 mL 1.9528 mL 4.8820 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

 

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

     

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
Melanotan (MT)-II
Art. -Nr.:
HY-P0267
Menge:
MCE Japan Authorized Agent: